Allmedx
Get Full AccessDescription
- AllMedx.com is a clinical search site designed for busy physicians and clinicians. Research shows that U.S. health care professionals have more than 1 billion clinical care queries a year for which they are struggling to find answers. To fill a gap that no other search engine can meet, AllMedx.com filters out irrelevant, unreliable, and consumer links, ensuring that search results contain the highest quality clinical information available. Special features of the site include unique search refinements through real-time, proprietary content clusters; a database of more than 2,000 clinical guidelines from 230 medical societies; drug and dosing resources; prefiltered Pubmed results; news and review articles from respected publishers; and information on more than 7,000 rare diseases. The site is free to users and is supported by advertising. Content Partnerships AllMedx is interested in building long-term strategic partnerships with medical publishers, medical societies, drug information sources, key opinion leaders, and other medical/clinical related groups and individuals.
-
Headquarters:555 Madison Avenue , New York, New York, United States
More -
Phone Number:
-
Website: http://www.allmedx.com
-
Employees:4
-
Revenue:$1 - 10M
-
Legal Name:Allmedx
-
Allmedx's Social Media
-
Is this data correct?
-
| NAICS Code: 621330 |
Show More
Frequently Asked Questions regarding Allmedx
-
Where are Allmedx's Headquarters?
Allmedx's Headquarters are in 555 Madison Avenue ,New York,New York,United States
-
What is Allmedx's official website?
Allmedx's official website is http://www.allmedx.com
-
What is Allmedx's Revenue?
Allmedx's revenue is $1 - 10M
-
What is Allmedx's NAICS code?
Allmedx's NAICS code is 621330
-
How many employees are working in Allmedx
Allmedx has 4 employees
-
What is Allmedx's Industry?
Allmedx is in the industry of Health, Wellness And Fitness
-
Who is Allmedx's CEO?
Allmedx's CEO is Carol
-
Who is Allmedx's Chief Technology Officer?
Allmedx's Chief Technology Officer is Michael Kephart

